Relationships between verapamil plasma concentrations and its antihypertensive action. 1988

A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
Psychiatric Hospital of Havana, Cuba.

Twenty-seven hypertensive outpatients were studied to evaluate the efficacy of verapamil after a single oral dose as well as following a short-term treatment and also in combination with oxprenolol. Blood pressure was significantly reduced (p 0.01) after verapamil monotherapy and the combined treatment. PR interval was lengthened from 30 min to 4 h during acute testing, and also after short-term treatment. QT was only prolonged after the verapamil monotherapy. Systolic time intervals (STIs) were not modified, except left ventricular ejection time (LVETc). Direct correlations were found among verapamil plasma concentrations and changes provoked on blood pressure and PR interval. The mean side effects found were disturbance of atrioventricular conduction in two patients without ulterior complications. The results suggest that verapamil monotherapy or in combination with oxprenolol could be useful in the treatment of essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
August 1987, Diabetes,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
February 1998, International journal of clinical pharmacology and therapeutics,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
August 2015, Animal science journal = Nihon chikusan Gakkaiho,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
January 1985, Journal of cardiovascular pharmacology,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
July 1989, Journal of cardiovascular pharmacology,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
January 1994, Gastroenterologie clinique et biologique,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
June 1998, Metabolism: clinical and experimental,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
March 1986, The American journal of cardiology,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
September 1985, Bratislavske lekarske listy,
A Gonzalez-Gomez, and M Cires Pujols, and F Gamio Capestany, and A Rodriguez de la Vega, and D Garcia-Barreto
August 1998, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!